Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial-Reference-Cited by-同舟云学术

Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial

Published:2011-02 Issue:2 Volume:11 Page:91-101
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Nicholson Karl G,Abrams Keith R,Batham Sally,Clark Tristan W,Hoschler Katja,Lim Wei Shen,Medina Marie-Jo,Nguyen-Van-Tam Jonathan S,Read Robert C,Warren Fiona C,Zambon Maria

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference32 articles.

1. Emergence of a novel swine origin influenza A virus in humans;Dawood;N Engl J Med,2009

2. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant;Vesikari;Pediatr Infect Dis,2009

3. Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months;Bernstein;Pediatrics,1982

4. Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza H9N2 vaccine preparations;Atmar;Clin Infect Dis,2006

5. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomized trial of two potential vaccines against H5N1 influenza;Nicholson;Lancet,2001

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Adjuvanted Influenza Vaccines;Vaccines;2023-08-21

2. Inactivated and Recombinant Influenza Vaccines;Plotkin's Vaccines;2023

3. Nanomedicine to deliver biological macromolecules for treating COVID-19;Vaccine;2022-06

4. Nanotechnology-based approaches against COVID-19;Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance;2022

5. Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond;Immunity & Ageing;2021-10-09